TYPHIM VI
Google image searchProduct monograph
Active ingredient
salmonella typhi ty2 vi capsular polysaccharide, 25 MCG/0.5 ML
DIN: 02130955
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Description: SINGLE-DOSE PREFILLED SYRINGE
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 06-SEP-2006
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
- J07AP — Typhoid vaccines (ATC, ATC/DDD)
- J07AP03 — TYPHOID, PURIFIED POLYSACCHARIDE ANTIGEN (ATC/DDD)
Reference brand drug: Typhim Vi